Hair loss is a widespread problem in the US, with roughly 50 million men and 30 million women experiencing pattern baldness.

A safer and more effective formulation of the most popular hair-loss treatment led to robust hair growth in a clinical trial.

Hair loss is common in both men and women but presents differently and requires tailored treatments. Treatment for men often involves medications like finasteride and minoxidil to slow genetic hair ...

Phase 2/3 trial data show VDPHL01, an oral non-hormonal extended-release minoxidil, improves hair growth and patient-reported outcomes in male pattern hair loss.

The extended-release minoxidil tablet could be the first FDA-approved oral treatment for pattern hair loss in about 30 years ...

The first signs of androgenetic alopecia, also known as male or female pattern hair loss, start with a slow burn: a receding hair line, a thinning part or a patch of hair that’s looking more sparse ...

We’re not surprised when men start to go bald, but hair loss for women happens, too—and it isn’t talked about enough. In fact ...

This marks the completion of enrollment of all male Phase 3 studies of VDPHL01 in pattern hair loss, with approximately 1,000 male patients enrolled across studies Topline data from initial '302' ...

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced it will host ...

This article was reviewed by Knox Beasley, MD. Have you run your hands through your hair and noticed a few too many strands falling out? Or maybe you’ve seen bald spots slowly grow bigger over the ...

The researchers used mouse skin samples to monitor changes to the fat tissue under the skin, as well as to the hair follicles and the cells that help hair grow, after they caused small injuries to ...